胸腔镜全肺切除术在非小细胞肺癌治疗中的作用:多中心研究
该多中心研究纳入2000-2016年3家机构因非转移性非小细胞肺癌行全肺切除术的359例患者,其中124例(35%)经胸腔镜(VATS)、235例(65%)经开胸完成。VATS组与开胸组的围术期死亡率和并发症发生率相似,5年生存率在多因素调整及倾向性评分匹配后均无显著差异。研究表明VATS全肺切除术可安全施行,肿瘤学结局至少不劣于开胸。
要点
- VATS全肺切除术围术期死亡率7% vs 开胸8%(P=.75),并发症均28%(P=.91)。
- 未调整5年生存率VATS 47%(95%CI 36-56)vs 开胸33%(95%CI 27-40),P=.19。
- 多因素调整后HR 0.76(95%CI 0.50-1.18,P=.23),匹配后OS无差异(P=.69)。
核心结论
- VATS全肺切除术可安全施行,肿瘤学结局至少不劣于开胸。
研究设计与样本
- 多中心回顾性队列研究,纳入3家机构2000-2016年因非转移性非小细胞肺癌行全肺切除术的359例患者。
- 排除完成性全肺切除术,采用意向性治疗分析,统计方法包括多因素logistic回归、Cox比例风险分析和倾向性评分匹配。
主要发现
- 359例中124例(35%)经VATS、235例(65%)经开胸行全肺切除术。
- 围术期死亡率VATS 7%(n=9)vs 开胸8%(n=19),P=.75;并发症发生率两组均为28%(VATS n=35 vs 开胸n=65),P=.91,多因素调整后仍相似。
- 未调整5年生存率VATS 47%(95%CI 36-56)vs 开胸33%(95%CI 27-40),P=.19;多因素调整后HR 0.76(95%CI 0.50-1.18),P=.23。
- 倾向性评分匹配平衡患者特征后,两组总生存无显著差异(P=.69)。
临床怎么用
- 在合适患者中,VATS全肺切除术可作为开胸全肺切除术的替代入路,围术期安全性与肿瘤学结局至少相当。
局限性
- VATS全肺切除术的作用仍需更多外科医生报告结果后才能进一步明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to evaluate the impact of the video-assisted thoracoscopic (VATS) approach on the outcomes of patients who underwent pneumonectomy. METHODS: The effect of the surgical approach on perioperative complications and survival in patients who underwent pneumonectomy for nonmetastatic non-small cell lung cancer across 3 institutions (2000-2016) was assessed using multivariable logistic regression, Cox proportional hazards analysis, and propensity-score matching. Completion pneumonectomies were excluded from this study, and an "intent-to-treat" analysis was performed. RESULTS: During the study period, 359 patients met inclusion criteria and underwent pneumonectomy for nonmetastatic non-small cell lung cancer; 124 (35%) underwent pneumonectomy via VATS and 235 (65%) via thoracotomy. Perioperative mortality (VATS, 7% [n = 9] vs open, 8% [n = 19]; P = .75) and morbidity (VATS, 28% [n = 35] vs open, 28% [n = 65]; P = .91) were similar between the groups, even after multivariable adjustment. VATS showed similar 5-year survival when compared with thoracotomy in unadjusted analysis (47% [95% confidence interval (CI), 36-56] vs 33% [95% CI, 27-40]; P = .19), even after multivariable adjustment (hazard ratio, 0.76 [95% CI, 0.50-1.18]; P = .23). In a propensity score-matched analysis that balanced patient characteristics, there were no significant differences found in overall survival between the 2 groups (P = .69). CONCLUSIONS: Although the role of VATS pneumonectomy will likely become clearer as more surgeons report results, this multicenter study suggests that the VATS approach for pneumonectomy can be performed safely, with at least equivalent oncologic outcomes when compared with thoracotomy.
引用
- Yang CJ, Yendamuri S, Mayne NR, et al. The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study. J Thorac Cardiovasc Surg. 2018. PMID: 30739773. doi:10.1016/j.jtcvs.2018.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。